SLC15A1 and inflammatory bowel disease: In human disease, colonic expression of PepT1 leads to bacterial di- and tripeptide uptake in epithelial cells, causing downstream chronic inflammation and is associated with numerous gastrointestinal tract disorders including inflammatory bowel disease (IBD) and colonic cancer (25, 26).